Pricing

Mineralys Therapeutics Inc (MLYS)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
CEO:
Jon Congleton
Employees:
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA, 19087
(888) 378-6240
We are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. We were originally founded as a Delaware corporation on May 31, 2019 under the name Catalys SC1, Inc. On May 29, 2020, we changed our name to Mineralys Therapeutics, Inc. Our principal executive offices are located at 150 N. Radnor Chester Road, Suite F200, Radnor, PA.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available